 critical evaluation new agents treatment sepsis OBJECTIVE new treatments endotoxin tumor necrosis factor alpha use sepsis related disorders sepsis syndrome septic shock DATA SOURCES Investigations treatments animal models healthy human volunteers patients sepsis related disorders STUDY SELECTION Particular attention studies patients sepsis related disorders double-blind trials DATA EXTRACTION Animal studies investigations human volunteers experimental model clinical disorder sepsis Patient trials sample size design Results studies likelihood treatment mortality DATA SYNTHESIS Direct comparison antibody studies difficult differences design definitions shock methods subgroup analysis antibodies outcome subgroups benefits patients gram-negative infection bacteremic focal refractory shock benefits gram-negative bacteremia regardless shock present focal gram-negative infection agents beneficial gram-positive gram-negative infection monoclonal antibodies necrosis factor alpha receptor antagonists Preliminary results CONCLUSIONS types treatment outcome sepsis results combination therapy multiple points inflammatory cascade sepsis